cardiovascular benefits of glp-1 agonists Receptor for the Reduction Atherosclerotic Risk in Patients With Type 2 Diabetes Cardiovascular Protective Properties of GLP-1
Description
Demand for these drugs has increased rapidly in recent years, as indications have expanded, but they remain expensive
Are you a candidate?
Coverage of GLP-1 weight-loss drugs is growing among the largest employers (5000+ workers), now at 43%
Easy once-a-day use
DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006
Loss of muscle mass and strength not only impairs mobility and quality of life, but also worsens insulin resistance, ...
